UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000044326
Receipt No. R000050628
Scientific Title Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.
Date of disclosure of the study information 2021/05/26
Last modified on 2021/05/25 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.
Acronym Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.
Scientific Title Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.
Scientific Title:Acronym Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.
Region
Japan

Condition
Condition Malignant glioma
Classification by specialty
Neurosurgery Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Compariozon of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes QOL:EORTC QLQ-C308
Anolexia:Numerical Rating Scale
Change of body weight, before and after treatment
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -but assessor(s) are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Olanzapine
Interventions/Control_2 Rikkunshito
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Patient of malignant glioma
Key exclusion criteria 1)Deep coma
2)Uncontrollable Diabetes mellitus
3)Heavy liver dysfunction
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Kosuke
Middle name
Last name Katayama
Organization Hirosaki University Graduate School of Medicine
Division name Department of neurosurgery
Zip code 036-8562
Address Zaifu-cho 5, Hirosaki-shi, Aomori, Japan
TEL +81-172-39-5115
Email k.kosuke@hirosaki-u.ac.jp

Public contact
Name of contact person
1st name Kosuke
Middle name
Last name Katayama
Organization Hirosaki University Graduate School of Medicine
Division name Department of neurosurgery
Zip code 036-8562
Address Zaifu-cho 5, Hirosaki-shi, Aomori, Japan
TEL +81-172-39-5115
Homepage URL
Email k.kosuke@hirosaki-u.ac.jp

Sponsor
Institute Hirosaki University Graduate School of Medicine
Institute
Department

Funding Source
Organization Hirosaki University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization crb-hirosaki
Address Zaifu-cho 5, Hirosaki-shi, Aomori, Japan
Tel +81-172-39-5362
Email crb-hirosaki@hirosaki-u.ac.jp

Secondary IDs
Secondary IDs YES
Study ID_1 17R01001
Org. issuing International ID_1 17R01001
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 05 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2019 Year 10 Month 02 Day
Date of IRB
2019 Year 10 Month 07 Day
Anticipated trial start date
2020 Year 05 Month 09 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 05 Month 25 Day
Last modified on
2021 Year 05 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050628